These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 25423066)

  • 1. Antiviral drugs for seasonal influenza 2014-2015.
    Med Lett Drugs Ther; 2014; 56(1457):121-3. PubMed ID: 25423066
    [No Abstract]   [Full Text] [Related]  

  • 2. Laninamivir octanoate: a new long-acting neuraminidase inhibitor for the treatment of influenza.
    Ikematsu H; Kawai N
    Expert Rev Anti Infect Ther; 2011 Oct; 9(10):851-7. PubMed ID: 21973296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiviral drugs for influenza.
    Med Lett Drugs Ther; 2008 Dec 15-29; 50(1301-1302):98-9, 104; quiz p following 104. PubMed ID: 19078865
    [No Abstract]   [Full Text] [Related]  

  • 4. [Controversies about neuraminidase inhibitor. Is the influenza drug less effective than assumed?].
    Haas W
    MMW Fortschr Med; 2010 Jan; 152(3):7. PubMed ID: 20333956
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-acting neuraminidase inhibitor laninamivir octanoate versus oseltamivir for treatment of influenza: A double-blind, randomized, noninferiority clinical trial.
    Watanabe A; Chang SC; Kim MJ; Chu DW; Ohashi Y;
    Clin Infect Dis; 2010 Nov; 51(10):1167-75. PubMed ID: 20936975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral management of seasonal and pandemic influenza.
    Hayden FG; Pavia AT
    J Infect Dis; 2006 Nov; 194 Suppl 2():S119-26. PubMed ID: 17163384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [New diagnostic possibilities and medications. Fit for influenza?].
    Wutzler P
    MMW Fortschr Med; 2002 Nov; 144(48):18. PubMed ID: 12532540
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacokinetics and dosage adjustment of oseltamivir and zanamivir in patients with renal failure.
    Karie S; Launay-Vacher V; Janus N; Izzedine H; Deray G
    Nephrol Dial Transplant; 2006 Dec; 21(12):3606-8. PubMed ID: 16799172
    [No Abstract]   [Full Text] [Related]  

  • 9. [Countermeasures for newly-emerging influenza].
    Sugaya N
    Nihon Naika Gakkai Zasshi; 2007 Nov; 96(11):2393-9. PubMed ID: 18069288
    [No Abstract]   [Full Text] [Related]  

  • 10. [Antiviral agents for influenza].
    Mitamura K
    Nihon Rinsho; 2007 Feb; 65 Suppl 2 Pt. 1():401-6. PubMed ID: 17455653
    [No Abstract]   [Full Text] [Related]  

  • 11. Two neuraminidase inhibitors for treatment of influenza.
    Med Lett Drugs Ther; 1999 Oct; 41(1063):91-3. PubMed ID: 10535051
    [No Abstract]   [Full Text] [Related]  

  • 12. Synthetic approaches to the neuraminidase inhibitors zanamivir (Relenza) and oseltamivir phosphate (Tamiflu) for the treatment of influenza.
    Magano J
    Chem Rev; 2009 Sep; 109(9):4398-438. PubMed ID: 19537777
    [No Abstract]   [Full Text] [Related]  

  • 13. [Neuraminidase inhibitor permitted. The first pill against influenza].
    MMW Fortschr Med; 2002 Oct; 144(41):56. PubMed ID: 12474367
    [No Abstract]   [Full Text] [Related]  

  • 14. Antiviral drugs for influenza 2012-2013.
    Med Lett Drugs Ther; 2012 Dec; 54(1405):97-8. PubMed ID: 23223245
    [No Abstract]   [Full Text] [Related]  

  • 15. Failure of combination oral oseltamivir and inhaled zanamivir antiviral treatment in ventilator- and ECMO-treated critically ill patients with pandemic influenza A (H1N1)v.
    Petersen E; Keld DB; Ellermann-Eriksen S; Gubbels S; Ilkjær S; Jensen-Fangel S; Lindskov C
    Scand J Infect Dis; 2011 Jul; 43(6-7):495-503. PubMed ID: 21309638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The additive effect of clarithromycin on influenza A infection in the elderly patients and patients with comorbid diseases.
    Yatera K; Umeki K; Yamasaki K; Noguchi S; Nishida C; Ishimoto H; Sakamoto N; Ishii H; Kadota JI; Mukae H
    Respir Investig; 2017 Nov; 55(6):380-383. PubMed ID: 29153420
    [No Abstract]   [Full Text] [Related]  

  • 17. In brief: concerns about oseltamivir (Tamiflu).
    Med Lett Drugs Ther; 2015 Jan; 57(1460):14. PubMed ID: 25536909
    [No Abstract]   [Full Text] [Related]  

  • 18. [Role of neuraminidase inhibitors for the treatment of influenza A virus infections].
    Ferraris O; Escuret V; Bouscambert-Duchamp M; Lina B; Morfin F
    Pathol Biol (Paris); 2010 Apr; 58(2):e69-78. PubMed ID: 20303677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oseltamivir resistance in influenza A (H5N1) infection.
    Gupta RK; Nguyen-Van-Tam JS
    N Engl J Med; 2006 Mar; 354(13):1423-4; author reply 1423-4. PubMed ID: 16571890
    [No Abstract]   [Full Text] [Related]  

  • 20. From neuraminidase inhibitors to conjugates: a step towards better anti-influenza drugs?
    Cheng CK; Tsai CH; Shie JJ; Fang JM
    Future Med Chem; 2014 May; 6(7):757-74. PubMed ID: 24941871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.